Current knowledge and future perspectives of exosomes as nanocarriers in diagnosis and treatment of diseases
Z Zou, H Li, G Xu, Y Hu, W Zhang… - International Journal of …, 2023 - Taylor & Francis
Exosomes, as natural nanocarriers, characterized with low immunogenicity, non-cytotoxicity
and targeted delivery capability, which have advantages over synthetic nanocarriers …
and targeted delivery capability, which have advantages over synthetic nanocarriers …
[HTML][HTML] Exosome nanovesicles: a potential carrier for therapeutic delivery
Exosomes are small nanosized biovesicles that form when multivesicular bodies and the
plasma membrane fuse and are released into the surrounding body fluids. They are best …
plasma membrane fuse and are released into the surrounding body fluids. They are best …
Exosomes harnessed as nanocarriers for cancer therapy-current status and potential for future clinical applications
Exosomes are nano structured (50-90 nm) vesicles that originate from endosomal
compartment of eukaryotic cells and are secreted into extracellular matrix. In recent years …
compartment of eukaryotic cells and are secreted into extracellular matrix. In recent years …
Exosomes as cutting-edge therapeutics in various biomedical applications: an update on engineering, delivery, and preclinical studies
Exosomes are cell-derived nanovesicles, circulating in different body fluids, and acting as an
intercellular mechanism. They can be purified from culture media of different cell types and …
intercellular mechanism. They can be purified from culture media of different cell types and …
[HTML][HTML] Exosomes: biological pharmaceutical nanovectors for theranostics
Exosomes are natural cell-derived nanovesicles of endocytic origin that enable cellular
crosstalk by transferring encapsulated molecular cargos across biological barriers, thereby …
crosstalk by transferring encapsulated molecular cargos across biological barriers, thereby …
Engineered Exosomes as Theranostic Platforms for Cancer Treatment
X Yang, X Xie, S Liu, W Ma, Z Zheng… - … Science & Engineering, 2023 - ACS Publications
Tremendous progress in nanotechnology and nanomedicine has made a significant positive
effect on cancer treatment by integrating multicomponents into a single multifunctional …
effect on cancer treatment by integrating multicomponents into a single multifunctional …
Exosomes as new generation vehicles for drug delivery systems
N Dilsiz - Journal of Drug Delivery Science and Technology, 2024 - Elsevier
Exosomes are the smallest subtype of mobile extracellular vesicles (EVs), and round sacs
with a diameter between 30 and 120 nm are released by almost all cell types into the …
with a diameter between 30 and 120 nm are released by almost all cell types into the …
Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications
MN Huda, M Nafiujjaman, IG Deaguero… - ACS biomaterials …, 2021 - ACS Publications
Exosomes are cell-derived vesicles containing heterogeneous active biomolecules such as
proteins, lipids, mRNAs, receptors, immune regulatory molecules, and nucleic acids. They …
proteins, lipids, mRNAs, receptors, immune regulatory molecules, and nucleic acids. They …
Targeted exosome-based nanoplatform for new-generation therapeutic strategies
W Yin, H Ma, Y Qu, S Wang, R Zhao, Y Yang… - Biomedical …, 2024 - iopscience.iop.org
Abstract Exosomes, typically 30–150 nm in size, are lipid-bilayered small-membrane
vesicles originating in endosomes. Exosome biogenesis is regulated by the coordination of …
vesicles originating in endosomes. Exosome biogenesis is regulated by the coordination of …
Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives
Abstract Exosomes are nanosized (size~ 30–150 nm) natural vesicular structures released
from cells by physiological processes or pathological circumstances. Exosomes are growing …
from cells by physiological processes or pathological circumstances. Exosomes are growing …